Genentech has stopped developing emugrobart after trial results showed no consistent benefit when added to Evrysdi in people ...

Genentech is halting development of an antibody for two rare genetic diseases after the candidate failed to boost muscle growth, raising questions about whether the molecule can preserve muscle in two ...

In a letter to European patients, Roche said its decision to end development of “emugrobart” was based on the drug “not consistently” improving muscle growth and motor function in a key study.

The big pharma company will no longer progress emugrobart to late-stage trials in FSHD and SMA due to a lack of efficacy.

The ACSM released new resistance training guidelines to improve muscle strength, size, and performance. medical News today ...

Original story from Technion-Israel Institute of Technology (Haifa, Israel). An implantable tissue flap containing muscle and ...

Positive 12-month Phase 2 data for NDV-01 in non-muscle invasive bladder cancer (NMIBC) demonstrated a 95% complete response (CR) rate at any time and a durable 76% CR rate at 12 months, with ...

Protein needs vary by goals, such as muscle gain or pregnancy. Getting the right amount of protein can help build muscle, support bone density, and meet pregnancy demands.

Patients with obesity sometimes have leptin resistance, and the "full" feeling does not get through to the brain. The new ...

In addition to its protein and omega-3 content, “Salmon is also one of the best natural food sources of vitamin D, which supports bone health, immune function and muscle strength—areas that become ...

Many people believe muscle growth slows down too much after 50—but fitness experts say that’s far from the truth. With the right approach, building strength and staying active is not only possible, ...

Sarepta Therapeutics says the FDA has agreed to review a regulatory package for Amondys 45 and Vyondys 53 after they failed a confirmatory trial, but whether the agency will agree to approve them is ...